Keywords: GSK, GlaxoSmithKline, Fiocruz, Synflorix

GSK and Brazil’s Fiocruz partner for new R&D effort and increased vaccine access

Article | 18 August 2009

Print This

UK drug giant GlaxoSmithKline says that it has launched a unique partnership with Brazil’s Oswaldo Cruz Foundation to develop ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in